TY - JOUR
T1 - Molecular mechanisms for the modulation of blood pressure and potassium homeostasis by the distal convoluted tubule
AU - Castañeda-Bueno, María
AU - Ellison, David H.
AU - Gamba, Gerardo
N1 - Funding Information:
We thank all members of the Molecular Physiology Unit for helpful discussions. This work was supported by DK51496 grant from NIH to DHE and GG, A1‐S‐8290 and 101720 grants from CONACyT, Mexico to GG and MC‐B, respectively, and IN201519 grant from UNAM: DGAPA‐PAPIIT to GG.
Funding Information:
We thank all members of the Molecular Physiology Unit for helpful discussions. This work was supported by DK51496 grant from NIH to DHE and GG, A1-S-8290 and 101720 grants from CONACyT, Mexico to GG and MC-B, respectively, and IN201519 grant from UNAM: DGAPA-PAPIIT to GG.
Publisher Copyright:
© 2021 The Authors. Published under the terms of the CC BY 4.0 license
PY - 2022/2/7
Y1 - 2022/2/7
N2 - Epidemiological and clinical observations have shown that potassium ingestion is inversely correlated with arterial hypertension prevalence and cardiovascular mortality. The higher the dietary potassium, the lower the blood pressure and mortality. This phenomenon is explained, at least in part, by the interaction between salt reabsorption in the distal convoluted tubule (DCT) and potassium secretion in the connecting tubule/collecting duct of the mammalian nephron: In order to achieve adequate K+ secretion levels under certain conditions, salt reabsorption in the DCT must be reduced. Because salt handling by the kidney constitutes the basis for the long-term regulation of blood pressure, losing salt prevents hypertension. Here, we discuss how the study of inherited diseases in which salt reabsorption in the DCT is affected has revealed the molecular players, including membrane transporters and channels, kinases, and ubiquitin ligases that form the potassium sensing mechanism of the DCT and the processes through which the consequent adjustments in salt reabsorption are achieved.
AB - Epidemiological and clinical observations have shown that potassium ingestion is inversely correlated with arterial hypertension prevalence and cardiovascular mortality. The higher the dietary potassium, the lower the blood pressure and mortality. This phenomenon is explained, at least in part, by the interaction between salt reabsorption in the distal convoluted tubule (DCT) and potassium secretion in the connecting tubule/collecting duct of the mammalian nephron: In order to achieve adequate K+ secretion levels under certain conditions, salt reabsorption in the DCT must be reduced. Because salt handling by the kidney constitutes the basis for the long-term regulation of blood pressure, losing salt prevents hypertension. Here, we discuss how the study of inherited diseases in which salt reabsorption in the DCT is affected has revealed the molecular players, including membrane transporters and channels, kinases, and ubiquitin ligases that form the potassium sensing mechanism of the DCT and the processes through which the consequent adjustments in salt reabsorption are achieved.
KW - SESAME/EAST syndrome
KW - epithelial transport
KW - familial hyperkalemic hypertension
KW - gitelman syndrome
KW - potassium
UR - http://www.scopus.com/inward/record.url?scp=85121437263&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121437263&partnerID=8YFLogxK
U2 - 10.15252/emmm.202114273
DO - 10.15252/emmm.202114273
M3 - Review article
C2 - 34927382
AN - SCOPUS:85121437263
SN - 1757-4676
VL - 14
JO - EMBO Molecular Medicine
JF - EMBO Molecular Medicine
IS - 2
M1 - e14273
ER -